Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Fish and Richardson
Moodys
AstraZeneca
Deloitte
Dow
McKinsey
Argus Health
McKesson

Generated: May 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,861,760

« Back to Dashboard

Summary for Patent: 4,861,760
Title: Ophthalmological composition of the type which undergoes liquid-gel phase transition
Abstract:The present invention relates to a pharmaceutical composition intended for contacting with a physiological liquid characterized in that said composition is intended to be administered as a non-gelled liquid form and is intended to gel in situ, this composition containing at least one polysaccharide in aqueous solution, of the type which undergoes liquid-gel phase transition gelling in situ under the effect of an increase in the ionic strength of said physiological liquid.
Inventor(s): Mazuel; Claude (Riom, FR), Friteyre; Marie-Claire (Riom, FR)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:06/911,606
Patent Claim Types:
see list of patent claims
Composition;

Drugs Protected by US Patent 4,861,760

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,861,760

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France85 14689Oct 03, 1985

International Family Members for US Patent 4,861,760

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Denmark 170500 ➤ Sign Up
European Patent Office 0227494 ➤ Sign Up 95C0013 Belgium ➤ Sign Up
France 2588189 ➤ Sign Up
Greece 862444 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Cipla
Moodys
Johnson and Johnson
Farmers Insurance
Covington
Fish and Richardson
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.